• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Latest AAHRPP accreditations include N.Y. State Department of Health

Latest AAHRPP accreditations include N.Y. State Department of Health

June 12, 2014
CenterWatch Staff

The Association for the Accreditation of Human Research Protection Programs has accredited three more organizations, including one of the nation's largest state health departments and India's national comprehensive cancer center. A nonprofit organization, AAHRPP provides accreditation for organizations that conduct or review human research and can demonstrate that their protections exceed the safeguards required by the U.S. government.

The newly accredited organizations are:

  • New York State Department of Health, Albany, N.Y., including the Wadsworth Center for Laboratories and Research
  • Sahyadri Hospital, Pune, India, including Sahyadri Clinical R&D Center, Sahyadri Speciality Hospital Deccan Gymkhana, Sahyadri Hospital Bopodi, Sahyadri Hospital Hadapsar, Sahyadri Hospital Kothrud, Sahyadri Munot Hospital Swargate, and Sahyadri Speciality Hospital Nagar Road
  • Tata Memorial Center, Mumbai, India, the national comprehensive center for cancer prevention, treatment, education and research.

These accreditations reflect increasing acknowledgment, in the public and private sectors worldwide, that the AAHRPP gold seal is the mark of a quality human research program, where protecting participants is a shared responsibility—and a top priority.

"Every AAHRPP accreditation signals an unwavering commitment to the global community—to all who participate in research and all who benefit from the knowledge gained," said Elyse Summers, AAHRPP president and CEO.

To earn AAHRPP accreditation, organizations must demonstrate they have built extensive safeguards into every level of their research operation and that they adhere to high standards for research. In today's global, collaborative research enterprise, organizations increasingly rely on AAHRPP accreditation status to help identify trusted research partners.

To date, AAHRPP has accredited organizations in 46 states, Canada, China, India, Mexico, Republic of Korea, Saudi Arabia, Singapore and Taiwan. All major U.S. independent IRBs have earned AAHRPP accreditation. In addition, more than 60% of U.S. research-intensive universities and over 65% of U.S. medical schools are either AAHRPP accredited or have begun the accreditation process. The NIH has earned accreditation, as has Pfizer, the largest industry sponsor of clinical research.

Upcoming Events

  • 07Jun

    Developing World-Class SOPs: Optimizing Quality and Compliance

  • 08Jun

    Implementing ICH E8 R1 Recommendations Increases Site and Participant Relationship Scoring Measures

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • MAGI East 2023

    MAGI East 2023 Preview: Janssen Reports on Environmental Impact of Trials

  • Complexity-360x240.png

    Phase 3 Trials Significantly Rising in Complexity, Says CSDD

  • Quality Level Scale

    Build Quality into Trials Like You’d Build a House, Says FDA’s BIMO Director

  • DE&I

    Trust-Building, Community Connection Still Essential to DE&I Efforts, Experts Say

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing